Skip to main content

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

DCP Participation at the American Association for Cancer Research Annual Meeting

Date: Friday, April 25, 2025 to Wednesday, April 30, 2025
Time: All Day

Consider attending these AACR sessions virtually or in-person to learn the latest from DCP.

AACR 2025 Annual Meeting in Chicago from April 25-30

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Saturday, April 26, 2025

ED20 - Early Detection of Primary Cancer and Minimal Residual Disease by Liquid Biopsies

EDUCATIONAL SESSION 8:00 AM - 9:30 AM CT
Room S100 BC (Grand Ballroom BC) - McCormick Place South (Level 1)
8:31 AM - 8:51 AM CT Liquid biopsy in early cancer detection
NCI Presenter:
- Sudhir Srivastava, DCP, NCI

Monday, April 28, 2025

PO.PR02.02 - Biomarkers and Molecular Targets for Prevention

POSTER 9:00 AM - 12:00 PM CT
Section 43
2373 / 16 - Colonic polyp preventive effect of rLON protease in FAP-rat intestinal polyposis model
NCI Presenters:
- Vignesh Gunasekharan, DCP, NCI
- Shizuko Sei, DCP, NCI

Tuesday, April 29, 2025

Session MS.PR01.01 - Hot Topics in Cancer Prevention: Development of Multi-Cancer Early Detection Tests, Assessment of the Immune Environment, Targets for Cancer Prevention, and Cancer Interception Trials

Minisymposium 3:35 PM - 3:50 PM CT
6427 - Nous-209 off-the-shelf neoantigen immunotherapy induces robust neoantigen T cell response with the potential to intercept cancer in Lynch syndrome carriers
NCI Presenters:
- Ellen Richmond, DCP, NCI
- Asad Umar, DCP, NCI

PO.PR02.01 - Development of Chemopreventive Agents and Preclinical Models

POSTER 2:00 PM - 5:00 PM CT
Section 48
6324 / 5 - Intercepting bladder cancer progression using androgen receptor inhibitor, apalutamide, in a carcinogen BBN-induced rat bladder tumor model
NCI Presenters:
- John Clifford, DCP, NCI
- Shizuko Sei, DCP, NCI
6332 / 13 - Targeting PARP for the prevention of BRCA1-deficient triple-negative breast cancers
NCI Presenters:
- John Clifford, DCP, NCI
- Shizuko Sei, DCP, NCI
6336 / 17 - Preclinical efficacy of TRAIL inducing ONC201 against carcinogen (NNK)-induced lung adenocarcinoma in A/J mouse model
NCI Presenters:
- Vignesh Gunasekharan, DCP, NCI
- Shizuko Sei, DCP, NCI35

FO04 - Unlocking the Power of PROs to Assess Tolerability in Cancer Clinical Trials

FORUM 5:00 PM - 6:30 PM CT
Room S401 - McCormick Place South (Level 4)
NCI Presenter:
- Lori Minasian, DCP, NCI

Wednesday, April 30, 2025

PO.IM01.09 - Overcoming Checkpoint Inhibition and Tumor Suppression

POSTER 9:00 AM - 12:00 PM
Section 39
7311 / 26 - Targeting STAT3 to prevent non-small cell lung cancer in patients with chronic obstructive pulmonary disease
NCI Presenter:
- Vignesh Gunasekharan, DCP, NCI

On-Demand sessions

NIH07 - Resources from the NCI-Sponsored Human Tumor Atlas Network

NCI Presenters:
- Sharmistha Ghosh-Janjigian, DCB, NCI
- Indu Kohaar, DCP, NCI
- Erin Beck, CBIIT, NCI

NIH11 - NCI Resources for Cancer Prevention and Interception Agent Discovery and Development

NCI Presenters:
- Robert H. Shoemaker, DCP, NCI
- Altaf Mohammed, DCP, NCI
- Lillian Kuo, DCB, NCI
- Vignesh Gunasekharan, DCP, NCI
- Brian Cholewa, DCP, NCI